JJournal of Nanobiotechnology28d agoMXene-based CRISPR/Cas9 nanoplatform targeting FABP5 for ROS amplification and synergistic photothermal/photodynamic therapy of cervical cancerChang-Qing Jiang·Yuanjing Hu·Zi-Chao Yan·Youchang Liu·Jing-Jing Zhang·Bin Yue·Meng Qiu·Zhen SongRead at Journal of NanobiotechnologyTagsNanoplatforms for cancer theranosticsBiomedical Engineering
